Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands

Oral Oncology

Volumn 43, Issue 6, 2007, Pages 580-585

  Ferrazzo, Kivia Linhares ^a   Alves Jr , Sergio Melo ^a   Santos, Elisa ^a   Martins, Marilia Trierveiler ^a   de Sousa, Suzana Machado ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adenoid cystic carcinoma; Galectin 3; Polymorphous low grade adenocarcinoma; Salivary glands

Indexed keywords

BETA GALACTOSIDE; GALECTIN 3; LECTIN;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SALIVARY GLAND CARCINOMA;

ADULT; AGED; CARCINOMA, ADENOID CYSTIC; CELL DIFFERENTIATION; FEMALE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34249795139     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.06.010     Document Type: Article

References (34)

1. Hyam D.M., Veness M.J., and Morgan G.J. Minor salivary gland carcinoma involving the oral cavity or oropharynx. Aust Dent J 49 (2004) 16-19
2. Boko E., Napo-Koura G., Kpemissi E., and Boko-Bessi L. Tumours of the accessory salivary glands. Epidemiological and anatomopathological aspects. Rev Laryngol Otol Rhinol 125 (2004) 233-237
3. Garden A.S., Weber R.S., Morrison W.H., Ang K.K., and Peters L.J. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 32 3 (1995) 619-626
4. Rapidis A.D., Givalos N., Gakiopoulou H., Faratzis G., Stavrianos S.D., Vilos G.A., et al. Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol 41 (2005) 328-335
5. Spiers A.S.D., Esseltine D.L.W., Ruckdeschel J.C., Davies J.N.P., and Horton J. Metastatic adenoid cystic carcinoma of salivary glands: case reports and review of the literature. Cancer Control 3 4 (1996) 336-342
6. Evans H.L., and Batsakis J.G. Polymorphous low-grade adenocarcinoma of minor salivary glands: a study of 14 cases of a distinctive neoplasm. Cancer 53 (1984) 935-942
7. Evans H.L., and Luna M.A. Polymouphous low-grade adenocarcinoma: a study of 40 cases with long-term follow up and an evaluation of the importance of papilary areas. Am J Surg Pathol 24 (2000) 1319-1328
8. Barnes L., Everson J.W., Reichart P., and Sidransky D. World healty organization classification of tumours. Pathology and genetics of head and neck tumours (2005), IARC Press, Lyon p. 221-4 [chapter 5]
9. Barondes S.H., Cooper D.N.W., Gitt M.A., and Leffler H. Galectins: structure and function of a large family of animal lectins. J Biol Chem 269 (1994) 20807-20810
10. Kasai K., and Hirabayashi J. Galectins: a family of animal lectins. J Biochem 119 (1996) 1-8
11. Hughes R.C. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochem Biophys Acta 1473 (1999) 172-185
12. Davidson P.J., Davis M.J., Patterson R.J., Ripoche M.A., Poirier F., and Wang J.L. Shuttling of galectin-3 between the nucleus and cytoplasm. Glycobiology 12 5 (2002) 329-337
13. Dumic J., Dabelic S., and Flögel M. Galectin-3: an open-ended story. Biochim Biophys Acta 1760 4 (2006) 616-635
14. Ellerhorst J., Troncoso P., Xu X.C., Lee J., and Lotan R. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer. Urol Res 27 5 (1999) 362-367
15. Pacis R.A., Pilat M.J., Pienta K.J., Wojno K., Raz A., Hogan V., et al. Decreased galectin-3 expression in prostate cancer. Prostate 44 (2000) 118-123
16. Nakamura M., Inufusa H., Adachi T., Aga M., Kurimoto M., Nakatani Y., et al. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 15 1 (1999) 143-148
17. Takenaka Y., Fukumori T., and Raz A. Galectin-3 and metastasis. Glycoconj J 19 (2004) 543-549
18. Coli A., Bigotti G., Zucchetti F., Negro F., and Massi G. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 40 1 (2002) 80-87
19. Herrmann M.E., LiVolsi V.A., Pasha T.L., Roberts S.A., Wojcik E.M., and Baloch Z.W. Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 126 6 (2002) 710-713
20. Takenaka Y., Inohara H., Yoshii T., Oshima K., Nakahara S., Akahani S., et al. Malignant transformation of thyroid follicular cells by galectin-3. Cancer Lett 195 1 (2003) 111-119
21. Mehrotra P., Okpokam A., Bouhaidar R., Johnson S.J., Wilson J.A., Davies B.R., et al. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 45 5 (2004) 493-500
22. Honjo Y., Inohara H., Akahani S., Yoshii T., Takenaka Y., Yoshida J., et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 6 12 (2000) 4635-4640
23. Penner C.R., Folpe A.L., and Budnick S.D. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol 15 (2002) 687-691
24. Teymoortash A., Pientka A., Schrader C., Tiemann M., and Werner J.A. Expression of galectin-3 in adenoid cystic carcinoma of the head and neck and its relationship with distant metastasis. J Cancer Res Clin Oncol 132 (2006) 51-56
25. Araújo V.C., Sousa S.O.M., Carvalho Y.R., and Araújo N.S. Application of immunohistochemistry in the diagnosis of salivary gland tumors. Appl Immunohistochem Mol Morphol 8 (2000) 195-202
26. Xu X.C., Sola Gallego J.J., Lotan R., and El-Naggar A.K. Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms. Int J Oncol 17 (2000) 271-276
27. Califice S., Castronovo V., Bracke M., and Van Den Brule F. Dual activities of galectin-3 in human prostate cancer: Tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene 23 (2004) 7527-7536
28. Van den Brule F.A., Waltregny D., Liu F.T., and Castronovo V. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer 89 4 (2000) 361-367
29. Takenaka Y., Fukumori T., Yoshii T., Oka N., Inohara H., Kim H.R., et al. Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol 24 (2004) 4395-4406
30. Araújo V.C., Carvalho Y.R., and Araújo N.S. Actin versus vimentin in myoepithelial cells of salivary gland tumours. A comparative study. Oral Surg Oral Med Oral Pathol 77 (1994) 387-391
31. Araújo V.C., and Sousa S.O.M. Expression of different keratins in salivary gland tumours. Oral Oncol 32B (1996) 14-18
32. Araujo V., Sousa S., Jaeger M., Jaeger R., Loyola A., Crivelini M., et al. Characterization of the cellular component of polymorphous low-grade adenocarcinoma by immunohistochemistry and electron microscopy. Oral Oncol 35 (1999) 164-172
33. Araújo V.C., Loducca S.V.L., Sousa S.O.M., Williams D.M., and Araújo N.S. The cribriform features of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma: cytokeratin and integrin expression. Annals of Diagnostic Pathology 5 (2001) 330-334
34. Loducca S.V.L., Raitz R., Araújo N.S., and Araújo V.C. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: comparative study of collagen IV, laminin and their integrin ligants (α2β1 and α3β1). Histopathol 37 (2000) 118-123